Loading clinical trials...
Loading clinical trials...
This is a global, multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study of NEOD001 as a single agent administered intravenously in adul...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Prothena Biosciences Ltd.
NCT05451771 · AL Amyloidosis
NCT06383143 · AL Amyloidosis, Smoldering Multiple Myeloma, and more
NCT06192979 · Amyloidosis; Systemic, AL Amyloidosis
NCT06569147 · AL Amyloidosis
NCT07250269 · Relapsed/Refractory AL Amyloidosis
City of Hope
Duarte, California
Stanford Cancer Institute (SCI)
Stanford, California
Colorado Blood Cancer Institute
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions